Pediatrix Medical Group, Inc.
$23.19
▲
2.32%
2026-04-21 08:05:00
www.pediatrix.com
NYQ: MD
Explore Pediatrix Medical Group, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.93 B
Current Price
$23.19
52W High / Low
$24.99 / $11.84
Stock P/E
11.69
Book Value
$10.68
Dividend Yield
—
ROCE
12.93%
ROE
20.28%
Face Value
—
EPS
$1.94
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
4,280
Beta
0.72
Debt / Equity
73.29
Current Ratio
1.66
Quick Ratio
1.66
Forward P/E
9.22
Price / Sales
0.93
Enterprise Value
$1.87 B
EV / EBITDA
7.41
EV / Revenue
0.98
Rating
Buy
Target Price
$21.33
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Chemed Corporation | $385.77 | 19.4 | $5.15 B | 0.62% | 27.27% | 25.28% | $593.8 / $365.2 | $71.44 |
| 2. | Guardian Pharmacy Services, Inc. | $37.34 | 48.3 | $2.38 B | — | 28.85% | 26.61% | $41.36 / $19.17 | $3.25 |
| 3. | Encompass Health Corporation | $103.27 | 18.68 | $10.28 B | 0.72% | 16.84% | 24.82% | $127.99 / $92.77 | $24.38 |
| 4. | U.S. Physical Therapy, Inc. | $75.72 | 28.66 | $431.66 M | 2.43% | 7.55% | 7.59% | $93.5 / $64.99 | $31.5 |
| 5. | DocGo Inc. | $0.68 | — | $64.06 M | — | -59.59% | -89.05% | $2.45 / $0.49 | $1.46 |
| 6. | NewGenIvf Group Limited | $2.19 | 0.08 | $1.32 M | — | -135.35% | 79.4% | $7,356 / $1.52 | $110.5 |
| 7. | National HealthCare Corporation | $166.58 | 21.66 | $2.6 B | 1.54% | 10.08% | 11.92% | $177.47 / $89.4 | $68.79 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 493.77 M | 492.88 M | 468.84 M | 458.36 M | 502.36 M | — |
| Operating Profit | 54.67 M | 74 M | 63.7 M | 38.71 M | 58.1 M | — |
| Net Profit | 33.68 M | 71.71 M | 39.26 M | 20.74 M | 30.48 M | — |
| EPS in Rs | 0.41 | 0.86 | 0.47 | 0.25 | 0.37 | 0.23 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.91 B | 2.01 B | 1.99 B | 1.97 B |
| Operating Profit | 231.09 M | 183.68 M | 157.85 M | 200 M |
| Net Profit | 165.39 M | -99.07 M | -60.41 M | 66.33 M |
| EPS in Rs | 1.99 | -1.19 | -0.73 | 0.8 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.25 B | 2.15 B | 2.22 B | 2.35 B |
| Total Liabilities | 1.38 B | 1.39 B | 1.37 B | 1.46 B |
| Equity | 865.85 M | 764.94 M | 849.06 M | 891.63 M |
| Current Assets | 763.51 M | 639.61 M | 483.45 M | 427.99 M |
| Current Liabilities | 458.91 M | 434.11 M | 388.95 M | 426.98 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 271.09 M | 206.57 M | 137.32 M | 166.94 M |
| Investing CF | -18.3 M | -35.41 M | -48.18 M | -56.95 M |
| Financing CF | -107.49 M | -14.48 M | -25.71 M | -487.55 M |
| Free CF | 252.63 M | 184.55 M | 104 M | 137.23 M |
| Capex | -18.46 M | -22.02 M | -33.33 M | -29.71 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.92% | 1.15% | — | — |
| Earnings Growth % | -64% | -191.07% | — | — |
| Profit Margin % | -4.92% | -3.03% | 3.36% | — |
| Operating Margin % | 9.13% | 7.91% | 10.14% | — |
| Gross Margin % | 22.57% | 21.13% | 23.68% | — |
| EBITDA Margin % | -1.41% | 1.5% | 7.95% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.